<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37887357</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2218-1989</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>25</Day></PubDate></JournalIssue><Title>Metabolites</Title><ISOAbbreviation>Metabolites</ISOAbbreviation></Journal><ArticleTitle>Hyperbaric Oxygen Therapy Counters Oxidative Stress/Inflammation-Driven Symptoms in Long COVID-19 Patients: Preliminary Outcomes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1032</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/metabo13101032</ELocationID><Abstract><AbstractText>Long COVID-19 patients show systemic inflammation and persistent symptoms such as fatigue and malaise, profoundly affecting their quality of life. Since improving oxygenation can oppose inflammation at multiple tissue levels, we hypothesized that hyperbaric oxygen therapy (HBOT) could arrest inflammation progression and thus relieve symptoms of COVID-19. We evaluated oxy-inflammation biomarkers in long COVID-19 subjects treated with HBOT and monitored with non-invasive methods. Five subjects (two athletes and three patients with other comorbidities) were assigned to receive HBOT: 100% inspired O<sub>2</sub> at 2.4 ATA in a multiplace hyperbaric chamber for 90 min (three athletes: 15 HBOT &#xd7; 5 days/wk for 3 weeks; two patients affected by Idiopathic Sudden Sensorineural Hearing Loss: 30 HBOT &#xd7; 5 days/wk for 6 weeks; and one patient with osteomyelitis: 30 HBOT &#xd7; 5 days/wk for week for 6 weeks and, after a 30-day break, followed by a second cycle of 20 HBOT). Using saliva and/or urine samples, reactive oxygen species (ROS), antioxidant capacity, cytokines, lipids peroxidation, DNA damage, and renal status were assessed at T1_pre (basal level) and at T2_pre (basal level after treatment), and the results showed attenuated ROS production, lipid peroxidation, DNA damage, NO metabolites, and inflammation biomarker levels, especially in the athletes post-treatment. Thus, HBOT may represent an alternative non-invasive method for treating long COVID-19-induced long-lasting manifestations of oxy-inflammation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mrakic-Sposta</LastName><ForeName>Simona</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7359-2690</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Physiology, National Research Council (IFC-CNR), 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vezzoli</LastName><ForeName>Alessandra</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-0277-163X</Identifier><AffiliationInfo><Affiliation>Institute of Clinical Physiology, National Research Council (IFC-CNR), 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garetto</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>ATIP Center for Hyperbaric Medicine, 35128 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paganini</LastName><ForeName>Matteo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-7556-6928</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camporesi</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-3548-1097</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giacon</LastName><ForeName>Tommaso Antonio</ForeName><Initials>TA</Initials><Identifier Source="ORCID">0000-0002-1155-0628</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellanoce</LastName><ForeName>Cinzia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Clinical Physiology, National Research Council (IFC-CNR), 20162 Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agrimi</LastName><ForeName>Jacopo</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosco</LastName><ForeName>Gerardo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6595-7944</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, 35122 Padova, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Metabolites</MedlineTA><NlmUniqueID>101578790</NlmUniqueID><ISSNLinking>2218-1989</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Electron Paramagnetic Resonance</Keyword><Keyword MajorTopicYN="N">HBOT</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID-19</Keyword><Keyword MajorTopicYN="N">non-invasive methods</Keyword><Keyword MajorTopicYN="N">oxidative stress</Keyword><Keyword MajorTopicYN="N">reactive oxygen species</Keyword><Keyword MajorTopicYN="N">saliva</Keyword><Keyword MajorTopicYN="N">urine</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>57</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37887357</ArticleId><ArticleId IdType="pmc">PMC10608857</ArticleId><ArticleId IdType="doi">10.3390/metabo13101032</ArticleId><ArticleId IdType="pii">metabo13101032</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization.  [(accessed on 5 June 2023)]; Available online:  http:who.int.</Citation></Reference><Reference><Citation>Hernandez Acosta R.A., Garrigos Z.E., Marcelin J.R., Vijayvargiya P. COVID-19 Pathogenesis and Clinical Manifestations. Infect. Dis. Clin. N. Am. 2022;36:231&#x2013;249. doi: 10.1016/j.idc.2022.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2022.01.003</ArticleId><ArticleId IdType="pmc">PMC8806149</ArticleId><ArticleId IdType="pubmed">35636898</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., Madhavan A.V., McGroder C., Stevens J.S., Cook J.R., Nordvig A.S., Shalev D., Sehrawat T.S., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce J.D., Shen Q., Cintron S.A., Hiebert J.B. Post-COVID-19 Syndrome. Nurs. Res. 2022;71:164&#x2013;174. doi: 10.1097/NNR.0000000000000565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000565</ArticleId><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Talwar D., Kumar S., Acharya S., Raisinghani N., Madaan S., Hulkoti V., Akhilesh A., Khanna S., Shah D., Nimkar S. Interleukin 6 and Its Correlation with COVID-19 in Terms of Outcomes in an Intensive Care Unit of a Rural Hospital: A Cross-sectional Study. Indian J. Crit. Care Med. 2022;26:39&#x2013;42. doi: 10.5005/jp-journals-10071-24075.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-24075</ArticleId><ArticleId IdType="pmc">PMC8783243</ArticleId><ArticleId IdType="pubmed">35110842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hojyo S., Uchida M., Tanaka K., Hasebe R., Tanaka Y., Murakami M., Hirano T. How COVID-19 induces cytokine storm with high mortality. Inflamm. Regener. 2020;40:37. doi: 10.1186/s41232-020-00146-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41232-020-00146-3</ArticleId><ArticleId IdType="pmc">PMC7527296</ArticleId><ArticleId IdType="pubmed">33014208</ArticleId></ArticleIdList></Reference><Reference><Citation>Buicu A.-L., Cernea S., Benedek I., Buico C.-F., Benedek T. Systemic Inflammation and COVID-19 Mortality in Patients with Major Noncommunicable Diseases: Chronic Coronary Syndromes, Diabetes and Obesity. J. Clin. Med. 2021;10:1545. doi: 10.3390/jcm10081545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081545</ArticleId><ArticleId IdType="pmc">PMC8067631</ArticleId><ArticleId IdType="pubmed">33916917</ArticleId></ArticleIdList></Reference><Reference><Citation>Saha P., Bose S., Srivastava A.K., Chaudhary A.A., Lall R., Prasad S. Jeopardy of COVID-19: Rechecking the Perks of Phytotherapeutic Interventions. Molecules. 2021;26:6783. doi: 10.3390/molecules26226783.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules26226783</ArticleId><ArticleId IdType="pmc">PMC8621307</ArticleId><ArticleId IdType="pubmed">34833873</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo P., Alvaro Benito Ballesteros A.V., Yeung S.P., Liu R., Saha A., Curtis L., Kaser M., Haggard M.P., Chekel L.G. COVCOG 2: Cognitive and Memory Deficits in Long COVID: A Second Publication From the COVID and Cognition Study. Front. Aging Neurosci. 2022;14:804937. doi: 10.3389/fnagi.2022.804937.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2022.804937</ArticleId><ArticleId IdType="pmc">PMC8967943</ArticleId><ArticleId IdType="pubmed">35370620</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodruff M.C., Bonham K.S., Anam F.A., Walker T.A., Faliti C.E., Ishii Y., Kaminski C.Y., Ruunstrom M.C., Cooper K.R., Truong A.D., et al. Chronic inflammation, neutrophil activity, and autoreactivity splits long COVID. Nat. Commun. 2023;14:4201. doi: 10.1038/s41467-023-40012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-40012-7</ArticleId><ArticleId IdType="pmc">PMC10349085</ArticleId><ArticleId IdType="pubmed">37452024</ArticleId></ArticleIdList></Reference><Reference><Citation>Grifoni E., Valoriani A., Cei F., Lamanna R., Gelli A.M.G., Ciambotti B., Vannucci V., Moroni F., Pelegatti L., Tarquini R., et al. Interleukin-6 as prognosticator in patients with COVID-19. J. Infect. 2020;81:452&#x2013;482. doi: 10.1016/j.jinf.2020.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.06.008</ArticleId><ArticleId IdType="pmc">PMC7278637</ArticleId><ArticleId IdType="pubmed">32526326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Gussoni M., Montorsi M., Porcelli S., Vezzoli A. Assessment of a Standardized ROS Production Profile in Humans by Electron Paramagnetic Resonance. Oxid. Med. Cell. Longev. 2012;2012:973927. doi: 10.1155/2012/973927.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/973927</ArticleId><ArticleId IdType="pmc">PMC3412105</ArticleId><ArticleId IdType="pubmed">22900129</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzino G., Irrera N., Cucinotta M., Pallio G., Mannino F., Ancoraci G., Squadrito F., Altavilla D., Bitto A. Oxidative Stress: Harms and Benefits for Human Health. Oxid. Med. Cell. Longev. 2017;2017:8416763. doi: 10.1155/2017/8416763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/8416763</ArticleId><ArticleId IdType="pmc">PMC5551541</ArticleId><ArticleId IdType="pubmed">28819546</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Michael Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2023;28:564&#x2013;578. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco G., Vezzani G., Mrakic Sposta S., Rizzato A., Enten G., Abou-Samra A., Malacrida S., Quartesan S., Vezzoli A., Camporesi E. Hyperbaric oxygen therapy ameliorates osteonecrosis in patients by modulating inflammation and oxidative stress. J. Enzyme Inhib. Med. Chem. 2018;33:1501&#x2013;1505. doi: 10.1080/14756366.2018.1485149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2018.1485149</ArticleId><ArticleId IdType="pmc">PMC6171420</ArticleId><ArticleId IdType="pubmed">30274530</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadanny A., Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10:958. doi: 10.3390/biom10060958.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10060958</ArticleId><ArticleId IdType="pmc">PMC7355982</ArticleId><ArticleId IdType="pubmed">32630465</ArticleId></ArticleIdList></Reference><Reference><Citation>University of Hawaii at Manoa Honor Society . In: Hyperbaric Oxygen Therapy Indications. 14th ed. Moon R., editor. Best Publishing Company; North Palm Beach, FL, USA: 2019.</Citation></Reference><Reference><Citation>Undersea and Hyperbaric Medical Society UHMS Guidelines for credentialing, privileging and supervision of hyperbaric oxygen therapy in the U.S.A. Undersea Hyperb. Med. 2018;45:117&#x2013;127. doi: 10.22462/01.02.2018.19.</Citation><ArticleIdList><ArticleId IdType="doi">10.22462/01.02.2018.19</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganini M., Bosco G., Perozzo F.A.G., Kohlscheen E., Sonda R., Bassetto F., Garetto G., Camporesi E.M., Thom S.R. The Role of Hyperbaric Oxygen Treatment for COVID-19: A Review. Adv. Exp. Med. Biol. 2021;1289:27&#x2013;35. doi: 10.1007/5584_2020_568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2020_568</ArticleId><ArticleId IdType="pubmed">32696443</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbins Y.T., Gonevski M., Cain C., Baitule S., Sharma K., Magar A., Patel K., Sankar S., Kyrou I., Ali A., et al. Hyperbaric oxygen therapy for the treatment of long COVID: Early evaluation of a highly promising intervention. Clin. Med. 2021;21:e629&#x2013;e632. doi: 10.7861/clinmed.2021-0462.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.2021-0462</ArticleId><ArticleId IdType="pmc">PMC8806311</ArticleId><ArticleId IdType="pubmed">34862223</ArticleId></ArticleIdList></Reference><Reference><Citation>Zilberman-Itskovich S., Catalogna M., Sasson E., Elman-Shina K., Amir Hadanny A., Lang E., Finci S., Polak N., Fishlev G., Korin C., et al. Hyperbaric oxygen therapy improves neurocognitive functions and symptoms of post-COVID condition: Randomized controlled trial. Sci. Rep. 2022;12:11252. doi: 10.1038/s41598-022-15565-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-15565-0</ArticleId><ArticleId IdType="pmc">PMC9276805</ArticleId><ArticleId IdType="pubmed">35821512</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellberg A., Abdel-Halim L., Hassler A., El Gharbi S., Al-Ezerjawi S., Bostr&#xf6;m E., Sundberg C.J., Pernow J., Medson K., Kowalski J.H., et al. Hyperbaric oxygen for treatment of long COVID-19 syndrome (HOT-LoCO): Protocol for a randomised, placebo-controlled, double-blind, phase II clinical trial. BMJ Open. 2022;12:e061870. doi: 10.1136/bmjopen-2022-061870.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2022-061870</ArticleId><ArticleId IdType="pmc">PMC9638753</ArticleId><ArticleId IdType="pubmed">36323462</ArticleId></ArticleIdList></Reference><Reference><Citation>Joli J., Buck P., Zipfel S., Stengel A. Post-COVID-19 fatigue: A systematic review. Front. Psychiatry. 2022;13:947973. doi: 10.3389/fpsyt.2022.947973.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2022.947973</ArticleId><ArticleId IdType="pmc">PMC9403611</ArticleId><ArticleId IdType="pubmed">36032234</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhaiyat A.M., Sasson E., Wang Z., Khairy S., Ginzarly M., Qureshi U., Fikree M., Efrati S. Hyperbaric oxygen treatment for long coronavirus disease-19: A case report. J. Med. Case Rep. 2022;16:80. doi: 10.1186/s13256-022-03287-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="pubmed">35168680</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitman M., Fuchs S., Tyomkin V., Hadanny A., Zilberman-Itskovich S., Efrati S. The effect of hyperbaric oxygen therapy on myocardial function in post-COVID-19 syndrome patients: A randomized controlled trial. Sci. Rep. 2023;13:9473. doi: 10.1038/s41598-023-36570-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-36570-x</ArticleId><ArticleId IdType="pmc">PMC10257166</ArticleId><ArticleId IdType="pubmed">37301934</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliaei S., Paranjkhoo P., SeyedAlinaghi S., Mehraeen E., Hackett D. Is There a Role for Hyperbaric Oxygen Therapy in Reducing Long-Term COVID-19 Sequelae? J. Clin. Med. 2023;12:2270. doi: 10.3390/jcm12062270.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12062270</ArticleId><ArticleId IdType="pmc">PMC10057206</ArticleId><ArticleId IdType="pubmed">36983270</ArticleId></ArticleIdList></Reference><Reference><Citation>Kjellberg A., Hassler A., Bostr&#xf6;m E., El Gharbi S., Al-Ezerjawi S., Kowalski J., Rodriguez-Wallberg K.A., Bruchfeld J., St&#xe5;hlberg M., Nygren-Bonnier M., et al. Hyperbaric oxygen therapy for long COVID (HOT-LoCO), an interim safety report from a randomised controlled trial. BMC Infect. Dis. 2023;23:33. doi: 10.1186/s12879-023-08002-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08002-8</ArticleId><ArticleId IdType="pmc">PMC9854077</ArticleId><ArticleId IdType="pubmed">36670365</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorenstein S.A., Castellano M.L., Slone E.S., Gillette B., Liu H., Alsamarraie C., Jacobson A.M., Wall S.P., Adhikari S., Swartz J.L., et al. Hyperbaric oxygen therapy for COVID-19 patients with respiratory distress: Treated cases versus propensity-matched controls. Undersea Hyperb. Med. 2020;47:405&#x2013;413. doi: 10.22462/03.07.2020.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.22462/03.07.2020.1</ArticleId><ArticleId IdType="pubmed">32931666</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilmshurst P., Bewley S., Murray P. Hyperbaric oxygen therapy for the treatment of long COVID. Clin. Med. 2023;23:99&#x2013;100. doi: 10.7861/clinmed.Let.23.1.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.7861/clinmed.Let.23.1.2</ArticleId><ArticleId IdType="pubmed">36697009</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitala D., &#x141;abu&#x15b; W., Kozielski J., Strzelec P., Nowak M., Knefel G., Dyjas P., Ma-terniak K., Kosmala J., Paj&#x105;k J., et al. Preliminary Research on the Effect of Hyperbaric Oxygen Therapy in Patients with Post-COVID-19 Syndrome. J. Clin. Med. 2023;12:308. doi: 10.3390/jcm12010308.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12010308</ArticleId><ArticleId IdType="pmc">PMC9821575</ArticleId><ArticleId IdType="pubmed">36615108</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A., Theodoridou M., Maltezou H.C. Post-COVID Syndrome: Incidence, Clinical Spectrum, and Challenges for Primary Healthcare Professionals. Arch. Med. Res. 2021;52:575&#x2013;581. doi: 10.1016/j.arcmed.2021.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: An overview. Diabetes Metab. Syndr. 2021;15:869&#x2013;875. doi: 10.1016/j.dsx.2021.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.04.007</ArticleId><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. COVID-19 and its sequelae: A platform for optimal patient care, discovery and training. J. Thromb. Thrombolysis. 2021;51:587&#x2013;594. doi: 10.1007/s11239-021-02375-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11239-021-02375-w</ArticleId><ArticleId IdType="pmc">PMC7838017</ArticleId><ArticleId IdType="pubmed">33501596</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang L.-L., Lin K.-H., Hsu A.-L., Wu C.-Y., Chang K.-C., Li Y.-C., Chen Y. Reliability and validity of a vertical numerical rating scale supplemented with a faces rating scale in measuring fatigue after stroke. Health Qual. Life Outcomes. 2015;13:91. doi: 10.1186/s12955-015-0290-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-015-0290-9</ArticleId><ArticleId IdType="pmc">PMC4486436</ArticleId><ArticleId IdType="pubmed">26122080</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Campen C., Linda M.C., Rowe P.C., Verheugt F.W.A., Visser F.C. Numeric Rating Scales Show Prolonged Post-exertional Symptoms After Orthostatic Testing of Adults With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Med. 2021;7:602894. doi: 10.3389/fmed.2020.602894.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.602894</ArticleId><ArticleId IdType="pmc">PMC7874746</ArticleId><ArticleId IdType="pubmed">33585505</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Vezzoli A., D&#x2019;Alessandro F., Paganini M., Dellanoce C., Cialoni D., Bosco G. Change in Oxidative Stress Biomarkers During 30 Days in Saturation Dive: A Pilot Study. Int. J. Environ. Res. Public Health. 2020;17:7118. doi: 10.3390/ijerph17197118.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17197118</ArticleId><ArticleId IdType="pmc">PMC7579105</ArticleId><ArticleId IdType="pubmed">32998440</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacon T.A., Bosco G., Vezzoli A., Dellanoce C., Cialoni D., Paganini M., Mrakic-Sposta S. Oxidative Stress and Motion Sickness in One Crew during Competitive Offshore Sailing. Sci. Rep. 2022;12:1142. doi: 10.1038/s41598-022-05219-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-05219-6</ArticleId><ArticleId IdType="pmc">PMC8782845</ArticleId><ArticleId IdType="pubmed">35064225</ArticleId></ArticleIdList></Reference><Reference><Citation>Brizzolari A., Bosco G., Vezzoli A., Dellanoce C., Barassi A., Paganini M., Cialoni D., Mrakic-Sposta S. Seasonal Oxy-Inflammation and Hydration Status in Non-Elite Freeskiing Racer: A Pilot Study by Non-Invasive Analytic Method. Int. J. Environ. Res. Public Health. 2023;20:3157. doi: 10.3390/ijerph20043157.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph20043157</ArticleId><ArticleId IdType="pmc">PMC9960265</ArticleId><ArticleId IdType="pubmed">36833850</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco G., Giacon T.A., Paolocci N., Vezzoli A., Noce C.D., Paganini M., Agrimi J., Garetto G., Cialoni D., D&#x2019;Alessandro N., et al. Dopamine/BDNF loss underscores narcosis cognitive impairment in divers: A proof of concept in a dry condition. Eur. J. Appl. Physiol. 2023;123:143&#x2013;158. doi: 10.1007/s00421-022-05055-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-022-05055-6</ArticleId><ArticleId IdType="pmc">PMC9813116</ArticleId><ArticleId IdType="pubmed">36214902</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Vezzoli A., Maderna L., Gregorini F., Montorsi M., Moretti S., Greco F., Cova E., Gussoni M. R(+)-Thioctic Acid Effects on Oxidative Stress and Peripheral Neuropathy in Type II Diabetic Patients: Preliminary Results by Electron Paramagnetic Resonance and Electroneurography. Oxid. Med. Cell. Longev. 2018;2018:1767265. doi: 10.1155/2018/1767265.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2018/1767265</ArticleId><ArticleId IdType="pmc">PMC5914101</ArticleId><ArticleId IdType="pubmed">29849866</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti S., Mrakic-Sposta S., Roncoroni L., Vezzoli A., Dellanoce C., Monguzzi E., Branchi F., Ferretti F., Lombardo V., Doneda L., et al. Oxidative stress as a biomarker for monitoring treated celiac disease. Clin. Transl. Gastroenterol. 2018;9:157. doi: 10.1038/s41424-018-0031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41424-018-0031-6</ArticleId><ArticleId IdType="pmc">PMC5992147</ArticleId><ArticleId IdType="pubmed">29880904</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzoli A., Mrakic-Sposta S., Montorsi M., Porcelli S., Vago P., Cereda F., Longo S., Maggio M., Narici M. Moderate Intensity Resistive Training Reduces Oxidative Stress and Improves Muscle Mass and Function in Older Individuals. Antioxidants. 2019;8:431. doi: 10.3390/antiox8100431.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8100431</ArticleId><ArticleId IdType="pmc">PMC6826968</ArticleId><ArticleId IdType="pubmed">31561586</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Gussoni M., Dellanoce C., Marzorati M., Montorsi M., Rasica L., Pratali L., D&#x2019;Angelo G., Martinelli M., Bastiani L., et al. Effects of acute and sub-acute hypobaric hypoxia on oxidative stress: A field study in the Alps. Eur. J. Appl. Physiol. 2021;121:297&#x2013;306. doi: 10.1007/s00421-020-04527-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-020-04527-x</ArticleId><ArticleId IdType="pubmed">33057877</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic Sposta S., Montorsi M., Porcelli S., Marzorati M., Healey B., Dellanoce C., Vezzoli A. Effects of Prolonged Exposure to Hypobaric Hypoxia on Oxidative Stress: Overwintering in Antarctic Concordia Station. Oxid. Med. Cell. Longev. 2022;2022:4430032. doi: 10.1155/2022/4430032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4430032</ArticleId><ArticleId IdType="pmc">PMC9078816</ArticleId><ArticleId IdType="pubmed">35535360</ArticleId></ArticleIdList></Reference><Reference><Citation>Leveque C., Mrakic Sposta S., Theunissen S., Germonpr&#xe9; P., Lambrechts K., Vezzoli A., Gussoni M., Levenez M., Laf&#xe8;re P., Guerrero F., et al. Oxidative Stress Response Kinetics after 60 Minutes at Different Levels (10% or 15%) of Normobaric Hypoxia Exposure. Int. J. Mol. Sci. 2023;24:10188. doi: 10.3390/ijms241210188.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241210188</ArticleId><ArticleId IdType="pmc">PMC10299340</ArticleId><ArticleId IdType="pubmed">37373334</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Vezzoli A., Rizzato A., Della Noce C., Malacrida S., Montorsi M., Paganini M., Cancellara P., Bosco G. Oxidative stress assessment in breath-hold diving. Eur. J. Appl. Physiol. 2019;119:2449&#x2013;2456. doi: 10.1007/s00421-019-04224-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-019-04224-4</ArticleId><ArticleId IdType="pubmed">31520216</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco G., Rizzato A., Quartesan S., Camporesi E., Mrakic-Sposta S., Moretti S., Balestra C., Rubini A. Spirometry and oxidative stress after rebreather diving in warm water. Undersea Hyperb. Med. 2018;45:191&#x2013;198. doi: 10.22462/03.04.2018.6.</Citation><ArticleIdList><ArticleId IdType="doi">10.22462/03.04.2018.6</ArticleId><ArticleId IdType="pubmed">29734571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco G., Paganini M., Giacon T.A., Oppio A., Vezzoli A., Dellanoce C., Moro T., Paoli A., Zanotti F., Zavan B., et al. Oxidative Stress and Inflammation, MicroRNA, and Hemoglobin Variations after Administration of Oxygen at Different Pressures and Concentrations: A Randomized Trial. Int. J. Environ. Res. Public Health. 2021;18:9755. doi: 10.3390/ijerph18189755.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18189755</ArticleId><ArticleId IdType="pmc">PMC8468581</ArticleId><ArticleId IdType="pubmed">34574676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S., Gussoni M., Moretti S., Pratali L., Giardini G., Tacchini P., Dellanoce C., Tonacci A., Mastorci F., Borghini A., et al. Effects of Mountain Ultra-Marathon Running on ROS Production and Oxidative Damage by Micro-Invasive Analytic Techniques. PLoS ONE. 2015;10:e0141780. doi: 10.1371/journal.pone.0141780.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141780</ArticleId><ArticleId IdType="pmc">PMC4634988</ArticleId><ArticleId IdType="pubmed">26540518</ArticleId></ArticleIdList></Reference><Reference><Citation>Green L.C., Wagner D.A., Glogowski J., Skipper P.L., Wishnok J.S., Tannenbaum S.R. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal. Biochem. 1982;126:131&#x2013;138. doi: 10.1016/0003-2697(82)90118-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0003-2697(82)90118-X</ArticleId><ArticleId IdType="pubmed">7181105</ArticleId></ArticleIdList></Reference><Reference><Citation>Napodano C., Call&#xe0; C., Fiorita A., Marino M., Taddei E., Di Cesare T., Passali G.C., Di Santo R., Stefanile A., Fantoni M., et al. Salivary Biomarkers in COVID-19 Patients: Towards a Wide-Scale Test for Monitoring Disease Activity. J. Pers. Med. 2021;11:385. doi: 10.3390/jpm11050385.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm11050385</ArticleId><ArticleId IdType="pmc">PMC8151878</ArticleId><ArticleId IdType="pubmed">34066701</ArticleId></ArticleIdList></Reference><Reference><Citation>Alwafi H.A., Ali S.S., Kotha S.B., Abuljadayel L.W., Ibrahim M., Noor Elahi I.R., Alwafi H.A., Almuhayawi M.S., Finkelman M.D., Nagla A. El-Shitany Elevated Salivary Inflammatory Biomarkers are Associated with SARS-CoV-2 Infection Severity. Can. J. Infect. Dis. Med. Microbiol. 2022;2022:1543918. doi: 10.1155/2022/1543918.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/1543918</ArticleId><ArticleId IdType="pmc">PMC9363936</ArticleId><ArticleId IdType="pubmed">35967091</ArticleId></ArticleIdList></Reference><Reference><Citation>Nourin Shakeeb N., Varkey P., Hynse A., Ajit A. Saliva as a Potential Specimen to Monitor IL-6, TNF-&#x3b1; and IL-10 in COVID-19 Patients. Inflammation. 2022;45:2368&#x2013;2374. doi: 10.1007/s10753-022-01698-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-022-01698-x</ArticleId><ArticleId IdType="pmc">PMC9177134</ArticleId><ArticleId IdType="pubmed">35676607</ArticleId></ArticleIdList></Reference><Reference><Citation>Vezzoli A., Dellanoce C., Mrakic-Sposta S., Montorsi M., Moretti S., Tonini A., Pratali L., Accinni R. Oxidative Stress Assessment in Response to Ultraendurance Exercise: Thiols Redox Status and ROS Production According to Duration of a Competitive Race. Oxid. Med. Cell. Longev. 2016;2016:6439037. doi: 10.1155/2016/6439037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/6439037</ArticleId><ArticleId IdType="pmc">PMC4967677</ArticleId><ArticleId IdType="pubmed">27504148</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C., Kraft K. Oxidative Stress and Hyper-Inflammation as Major Drivers of Severe COVID-19 and Long COVID: Implications for the Benefit of High-Dose Intravenous Vitamin C. Front. Pharmacol. 2022;13:899198. doi: 10.3389/fphar.2022.899198.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId><ArticleId IdType="pmc">PMC9100929</ArticleId><ArticleId IdType="pubmed">35571085</ArticleId></ArticleIdList></Reference><Reference><Citation>Passos F.R.S., Heimfarth L., Monteiro B.S., Corr&#xea;a C.B., Moura T.R., Ara&#xfa;jo A.A.S., Martins-Filho P.R., Quintans-J&#xfa;nior L.J., Quintans J.S.S. Oxidative stress and inflammatory markers in patients with COVID-19: Potential role of RAGE, HMGB1, GFAP and COX-2 in disease severity. Int. Immunopharmacol. 2022;104:108502. doi: 10.1016/j.intimp.2021.108502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108502</ArticleId><ArticleId IdType="pmc">PMC8730710</ArticleId><ArticleId IdType="pubmed">35063743</ArticleId></ArticleIdList></Reference><Reference><Citation>Aj&#x10d;evi&#x107; M., Iscra K., Furlanis G., Michelutti M., Miladinovi&#x107; A., Buoite Stella A., Ukmar M., Cova M.A., Accardo A., Manganotti P., et al. Cerebral hypoperfusion in post-COVID-19 cognitively impaired subjects revealed by arterial spin labeling MRI. Sci. Rep. 2023;13:5808. doi: 10.1038/s41598-023-32275-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-32275-3</ArticleId><ArticleId IdType="pmc">PMC10086005</ArticleId><ArticleId IdType="pubmed">37037833</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. 18 F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D., Chalon P., Kohn L., Dauvrin M., Detollenaere J., Maertens de Noordhout C., Primus-de Jong C., Cleemput I., Van den Heede K. Pathophysiology and mechanism of long COVID: A comprehensive review. Ann. Med. 2022;54:1473&#x2013;1487. doi: 10.1080/07853890.2022.2076901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>De Pace N.L., Colombo J. Long-COVID Syndrome and the Cardiovascular System: A Review of Neurocardiologic Effects on Multiple Systems. Curr. Cardiol. Rep. 2022;24:1711&#x2013;1726. doi: 10.1007/s11886-022-01786-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11886-022-01786-2</ArticleId><ArticleId IdType="pmc">PMC9524329</ArticleId><ArticleId IdType="pubmed">36178611</ArticleId></ArticleIdList></Reference><Reference><Citation>Halbach J.L., Prieto J.M., Wang A.W., Hawisher D., Cauvi D.M., Reyes T., Okerblom J., Ramirez-Sanchez I., Villarreal F., Patel H.H., et al. Early hyperbaric oxygen therapy improves survival in a model of severe sepsis. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2019;317:R160&#x2013;R168. doi: 10.1152/ajpregu.00083.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00083.2019</ArticleId><ArticleId IdType="pmc">PMC6692752</ArticleId><ArticleId IdType="pubmed">31091156</ArticleId></ArticleIdList></Reference><Reference><Citation>Thom S.R. Oxidative stress is fundamental to hyperbaric oxygen therapy. J. Appl. Physiol. 2009;106:988&#x2013;995. doi: 10.1152/japplphysiol.91004.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.91004.2008</ArticleId><ArticleId IdType="pmc">PMC2660252</ArticleId><ArticleId IdType="pubmed">18845776</ArticleId></ArticleIdList></Reference><Reference><Citation>Salhanick S.D., Belikoff B., Orlow D., Holt D., Reenstra W., Buras J.A. Hyperbaric oxygen reduces acetaminophen toxicity and increases HIF-1alpha expression. Acad. Emerg. Med. 2006;13:707&#x2013;714. doi: 10.1197/j.aem.2006.01.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1197/j.aem.2006.01.029</ArticleId><ArticleId IdType="pubmed">16636360</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanja Novak S., Drenjancevic I., Vukovic R., Kellermayer Z., Cosic A., Levak M.T., Balogh P., Culo F., Mihalj M. Anti-inflammatory effects of hyperbaric oxygenation during DSS-induced colitis in BALB/c mice include changes in gene expression of HIF-1alpha, proinflammatory cytokines, and antioxidative enzymes. Mediat. Inflamm. 2016;2016:7141430. doi: 10.1155/2016/7141430.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/7141430</ArticleId><ArticleId IdType="pmc">PMC5021505</ArticleId><ArticleId IdType="pubmed">27656047</ArticleId></ArticleIdList></Reference><Reference><Citation>De Wolde S.D., Hulskes R.H., de Jonge S.W., Hollmann M.W., van Hulst R.A., Weenink R.P., Matthijs Kox M. The Effect of Hyperbaric Oxygen Therapy on Markers of Oxidative Stress and the Immune Response in Healthy Volunteers. Front. Physiol. 2022;13:826163. doi: 10.3389/fphys.2022.826163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2022.826163</ArticleId><ArticleId IdType="pmc">PMC8843016</ArticleId><ArticleId IdType="pubmed">35173631</ArticleId></ArticleIdList></Reference><Reference><Citation>Phetsouphanh C., Darley D.R., Wilson D.B., Howe A., Munier C.M.L., Patel S.K., Juno J.A., Burrell L.M., Kent S.J., Dore G.J., et al. Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection. Nat. Immunol. 2022;23:210&#x2013;216. doi: 10.1038/s41590-021-01113-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01113-x</ArticleId><ArticleId IdType="pubmed">35027728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulthei&#xdf; C., Willscher E., Paschold L., Gottschick C., Klee B., Glasauer S., Bosurgi L., Dutzmann J., Sedding D., Frese T., et al. From online data collection to identification of disease mechanisms: The IL-1&#xdf;, IL-6 and TNF-&#x3b1; cytokine triad is associated with post-acute sequelae of COVID-19 in a digital research cohort. SSRN Electron. J. 2021;3:100663. doi: 10.2139/ssrn.3963839.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.3963839</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R.N., Low R.J., Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Son Y., Cheong Y.K., Kim N.H., Chung H.T., Kang D.G., Pae H.O. Mitogen-activated protein kinases and reactive oxygen species: How can ROS activate MAPK pathways? J. Signal. Transduct. 2011;2011:792639. doi: 10.1155/2011/792639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2011/792639</ArticleId><ArticleId IdType="pmc">PMC3100083</ArticleId><ArticleId IdType="pubmed">21637379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin C.-S., Lee T.-Y., Chen Y.-W., Wu M.-F. Idiopathic Sudden Sensorineural Hearing Loss: Is Hyperbaric Oxygen Treatment the Sooner and Longer, the Better? J. Pers. Med. 2022;12:1652. doi: 10.3390/jpm12101652.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12101652</ArticleId><ArticleId IdType="pmc">PMC9605195</ArticleId><ArticleId IdType="pubmed">36294791</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim T.D., Lee S., Yoon S. Inflammation in Post-Traumatic Stress Disorder (PTSD): A Review of Potential Correlates of PTSD with a Neurological Perspective. Antioxidants. 2020;9:107. doi: 10.3390/antiox9020107.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox9020107</ArticleId><ArticleId IdType="pmc">PMC7070581</ArticleId><ArticleId IdType="pubmed">31991875</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonkoue I.T., Parvar J.P., Norrholm S., Li Y., Kankam M.L., Jones T.N., Vermulapalli M., Rothbaum B., Bremner J.D., Le N.-H., et al. Symptom severity impacts sympathetic dysregulation and inflammation in post-traumatic stress disorder (PTSD) Brain Behav. Immun. 2020;83:260&#x2013;269. doi: 10.1016/j.bbi.2019.10.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2019.10.021</ArticleId><ArticleId IdType="pmc">PMC6906238</ArticleId><ArticleId IdType="pubmed">31682970</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S., Cristillo V., Camera G., Morotti Colleoni C., Pellitteri G., Viti B., Bianchi E., Gipponi S., Grimoldi M., Valente M., et al. Incidence and Long-term Functional Outcome of Neurologic Disorders in Hospitalized Patients with COVID-19 Infected with Pre-Omicron Variants. Neurology. 2023;101:e892&#x2013;e903. doi: 10.1212/WNL.0000000000207534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000207534</ArticleId><ArticleId IdType="pmc">PMC10501088</ArticleId><ArticleId IdType="pubmed">37414564</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., Engl M., Romanello R., Nardone R., Bonini I., Koch G., Saltuari L., Quartarone A., et al. Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. J. Neurol. Sci. 2021;420:117271. doi: 10.1016/j.jns.2020.117271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2020.117271</ArticleId><ArticleId IdType="pmc">PMC7834526</ArticleId><ArticleId IdType="pubmed">33359928</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace A., Sebastianelli L., Ferrazzoli D., Romanello R., Ortelli P., Saltuari L., D&#x2019;Acunto A., Porrazzini F., Ajello V., Oliviero A., et al. Intracortical GABAergic dysfunction in patients with fatigue and dysexecutive syndrome after COVID-19. Clin. Neurophysiol. 2021;132:1138&#x2013;1143. doi: 10.1016/j.clinph.2021.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2021.03.001</ArticleId><ArticleId IdType="pmc">PMC7954785</ArticleId><ArticleId IdType="pubmed">33774378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarlone G.E., Hinojo C.M., Stavitzski N.M., Dean J.B. CNS function and dysfunction during exposure to hyperbaric oxygen in operational and clinical settings. Redox Biol. 2019;27:101159. doi: 10.1016/j.redox.2019.101159.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101159</ArticleId><ArticleId IdType="pmc">PMC6859559</ArticleId><ArticleId IdType="pubmed">30902504</ArticleId></ArticleIdList></Reference><Reference><Citation>Izquierdo-Alventosa R., Ingl&#xe8;s M., Cort&#xe9;s-Amador S., Gimeno-Mallench L., Sempere-Rubio N., Chirivella J., Serra-A&#xf1;&#xf3; P. Comparative study of the effectiveness of a low-pressure hyperbaric oxygen treatment and physical exercise in women with fi-bromyalgia: Randomized clinical trial. Ther. Adv. Musculoskelet Dis. 2020;12:1759720X20930493. doi: 10.1177/1759720X20930493.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1759720X20930493</ArticleId><ArticleId IdType="pmc">PMC7315668</ArticleId><ArticleId IdType="pubmed">32636943</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinkowska A.B., Mankowska N.D., Kot J., Winklewski P.J. Impact of Hyperbaric Oxygen Therapy on Cognitive Functions: A Systematic Review. Neuropsychol. Rev. 2022;32:99&#x2013;126. doi: 10.1007/s11065-021-09500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-021-09500-9</ArticleId><ArticleId IdType="pmc">PMC8888529</ArticleId><ArticleId IdType="pubmed">33847854</ArticleId></ArticleIdList></Reference><Reference><Citation>Versace V., Ortelli P., Dezi S., Ferrazzoli D., Alibardi A., Bonini I., Engl M., Maestri R., Assogna M., Ajello V., et al. Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome. Clin. Neurophysiol. 2023;145:81&#x2013;88. doi: 10.1016/j.clinph.2022.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2022.10.017</ArticleId><ArticleId IdType="pmc">PMC9650483</ArticleId><ArticleId IdType="pubmed">36455453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>